{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:34:41Z","timestamp":1764401681914},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/inf.0000000000001395","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T18:27:07Z","timestamp":1478975227000},"page":"e45-e47","source":"Crossref","is-referenced-by-count":9,"title":["Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine"],"prefix":"10.1097","volume":"36","author":[{"given":"Sirintip","family":"Sricharoenchai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keswadee","family":"Lapphra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunate","family":"Chuenkitmongkol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanatpreeya","family":"Phongsamart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Bouckenooghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orasri","family":"Wittawatmongkol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supattra","family":"Rungmaitree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kulkanya","family":"Chokephaibulkit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210202","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review.","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"key":"R2-19-20210202","first-page":"69","article-title":"Japanese encephalitis vaccines: WHO position paperFebruary 2015.","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"R3-19-20210202","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4161\/hv.6.12.13057","article-title":"Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults.","volume":"6","author":"Nasveld","year":"2010","journal-title":"Hum Vaccin"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.vaccine.2008.01.021","article-title":"A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.","volume":"26","author":"Sohn","year":"2008","journal-title":"Vaccine"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4161\/hv.23087","article-title":"Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.","volume":"9","author":"Feroldi","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.99.2.285","article-title":"A plaque reduction test for dengue virus neutralizing antibodies.","volume":"99","author":"Russell","year":"1967","journal-title":"J Immunol"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/INF.0000000000000276","article-title":"Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.","volume":"33","author":"Feroldi","year":"2014","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T22:05:42Z","timestamp":1692569142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201702000-00019"}},"subtitle":["A Phase IV Study in Thai Children"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001395","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}